Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2007

View Archived Issues

Enzymatic combinatorial approach for synthesizing new anticoagulant heparan sulfate derivatives

Alte Biosciences secures rights for therapeutics targeting late-onset depression

Positive phase IIb results for elocalcitol in BPH

Phase II omiganan study demonstrates positive results

Allergan acquires Esprit Pharma

EnVivo reports progress on major drug programs

Novel contraceptive agents reported in recent Wyeth patent

Phase I testing commences for SAR-3419 in non-Hodgkin's lymphoma

Positive interim safety data found for Vical's phase II CMV vaccine trial

Second OvaRex MAb phase III trial reaches 118th relapse event

Pharmion initiates pivotal phase III amrubicin study in small cell lung cancer

Genentech announces third quarter 2007 results

ConjuChem reports final results of PC-DAC:Exendin-4 phase I/II trial

Initial results of phase II boceprevir study show high early virologic response

Affectis initiates phase II trial for cimicoxib in depression

Galenica acquires Aspreva

Isis adds new drug, ISIS-388626, to pipeline for the treatment of type 2 diabetes

Recent Prolysis patent discloses new antiinfective agents

Novel agents for treating diabetes disclosed in recent patent literature

Micromet receives regulatory approval to conduct a phase II MT-103 trial

Analysis of phase III desmoteplase trial justifies continued development

Abraxis BioScience's Abraxane receives positive opinion in Europe

Neuroprotection by C2-8, a polyglutamine aggregation inhibitor, in Huntington's disease model

GlaxoSmithKline's once-daily Avamys receives positive opinion in Europe

FDA approves sanofi pasteur's meningococcal vaccine for children

Targin improves opioid-induced bowel dysfunction in patients with chronic pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...